News and Scientific Highlights
Controlling topological states in bilayer graphene
Parameters of topological channels created in twisted bilayer graphene can be controlled by lithium atoms intercalation.
Hairy cells: How cilia’s motor works
Understanding this motion may help to tackle health problems that affect cilia, which range from fertility issues to lung disease and COVID-19.
Imaging biomarkers for Alzheimer’s disease
Artificial intelligence pinpoints cells indicative of Alzheimer’s disease based on DNA packing in mouse brain images, shows study in Nature Communications
Automated synapse-level reconstruction of neural circuits in the larval zebrafish brain
Researchers from the Max Planck Institute for Biological Intelligence, Google Inc. and the Paul Scherrer Institute published a new method and data resource that makes connectomic analyses of the entire larval zebrafish brain possible.
Paul Scherrer Institute and Apollo Health Ventures Launch Focal Biosciences
Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases.
Millions in funding for brain and quantum research
The European Research Council approves PSI projects for the development of a quantum computer and brain research worth about 5 million euros.
Biased signalling for better drugs
A dream drug would provide a targeted therapeutic effect without side effects. Biased signalling could make this a reality. Publishing in PNAS, PSI researchers present a platform for biased signalling-based drug discovery.
Fingerprint of Copper in Peptides Linked to Alzheimer's Disease
In an interdisciplinary project, researchers from the Laboratory of Nanoscale Biology in BIO and the Laboratory for Condensed Matter in PSD have revealed the reaction between the nitrogen atoms of the amyloid-beta peptide and copper/zinc ions by using soft X-ray absorption spectroscopy.
Protein distancing
PSI researchers have developed a new method to attach proteins to the surface of virus-like particles.